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Abstract
Background: We previously demonstrated that unvaccinated macaques infected with large-dose M.tuberculosis(Mtb)
exhibited delays for pulmonary trafficking of Ag-specific ab and cd T effector cells, and developed severe lung
tuberculosis(TB) and ‘‘secondary’’ Mtb infection in remote organs such as liver and kidney. Despite delays in lungs, local
immunity in remote organs may accumulate since progressive immune activation after pulmonary Mtb infection may allow
IFNc-producing cd T cells to adequately develop and traffic to lately-infected remote organs. As initial efforts to test this
hypothesis, we comparatively examined TCR repertoire/clonality, tissue trafficking and effector function of Vc2Vd2 T cells in
lung with severe TB and in liver/kidney without apparent TB.
Methodology/Principal Findings: We utilized conventional infection-immunity approaches in macaque TB model, and
employed our decades-long expertise for TCR repertoire analyses. TCR repertoires in Vc2Vd2 T-cell subpopulation were
broad during primary Mtb infection as most TCR clones found in lymphoid system, lung, kidney and liver were distinct.
Polyclonally-expanded Vc2Vd2 T-cell clones from lymphoid tissues appeared to distribute and localize in lung TB granuloms
at the endpoint after Mtb infection by aerosol. Interestingly, some TCR clones appeared to be more predominant than
others in lymphocytes from liver or kidney without apparent TB lesions. TCR CDR3 spetratyping revealed such clonal
dominance, and the clonal dominance of expanded Vc2Vd2 T cells in kidney/liver tissues was associated with undetectable
or low-level TB burdens. Furthermore, Vc2Vd2 T cells from tissue compartments could mount effector function for
producing anti-mycobacterium cytokine.
Conclusion: We were the first to demonstrate clonal immune responses of mycobacterium-specific Vc2Vd2 T cells in the
lymphoid system, heavily-infected lungs and lately subtly-infected kidneys or livers during primary Mtb infection. While
clonally-expanded Vc2Vd2 T cells accumulated in lately-infected kidneys/livers without apparent TB lesions, TB burdens or
lesions appeared to impact TCR repertoires and tissue trafficking patterns of activated Vc2Vd2 T cells.
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Introduction
Tuberculosis(TB) remains one of the major causes of global
morbidity and mortality, and has become increasingly prevalent
and deadly as a result of HIV/AIDS pandemic and the emergence
of extensively drug resistant (XDR) strains of M. tuberculosis [1,2].
Elucidation of essential components of immunity against TB in
humans may help to design better vaccines or immunotherapeutics
for ultimate control of global TB pandemics [3]. Whereas studies
in murine TB model show that Th1 cells and IFNc or TNFa are
important for protection against active Mtb infection [4,5], the
role of CD4+ T cells in anti-TB immunity is also implicated in
HIV-infected humans and SIVmac-infected macaques [6,7].
Moreover, the contribution of memory CD8+ T cells to resistance
to TB has recently been demonstrated in nonhuman primates [8].
Nevertheless, a correlation between blood Th1 cells or IFNc and
anti-TB immunity in HIV-negative individuals has not been found
[4]. Recent mechanistic studies of BCG vaccine-induced anti-TB
immunity in macaques suggest that rapid pulmonary trafficking
and accumulation of vaccine-elicited CD4+ and CD8+ T effector
cells after Mtb infection may be one of immune mechanisms for
protection [9]. However, while .90% of humans resist to active
TB after Mtb exposure [10], little is known about how human
immune cells control a primary Mtb infection. Investigating
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30631primary immune responses of various helper T cells and cytotoxic
T cells including antigen-specific cd T cells may help to identify
effective or orchestrated immunity to primary Mtb infection.
Mycobacterium-specific Vc2Vd2 T cells exist only in humans
and nonhuman primates. Accumulating evidence suggests that
Vc2Vd2 T cells can contribute to both innate and adaptive
immune responses in infections [11]. We and others have
demonstrated that Vc2Vd2 T cells can be specifically activated
and expanded by phosphoantigen (E)-4-hydroxy-3-methyl-but-2-
enyl pyrophosphate (HMBPP) produced by Mtb and other
selected pathogens, and that soluble Vc2Vd2 TCR can bind to
HMBPP presented by APC [11,12,13,14,15]. Importantly,
Vc2Vd2 T cells can mount major expansion during mycobacte-
rium infections, and rapid recall-like expansion of these cd T cells
after Mtb challenge of BCG-vaccinated macaques is associated
with BCG-induced protection against fatal TB in juvenile rhesus
macaques [11]. Furthermore, major expansion of Vc2Vd2T
effector cells after HMBPP+ IL-2 post-challenge treatment can
also lead to homeostatic protection against severe pneumonic
plague lesions after inhalational Y. pestis infection of macaques
[16]. However, a definitive role of Vc2Vd2 T cells in anti-TB
immunity remains to be determined, and the definition requires
in-depth studies of immune biology of these HMBPP-specific
Vc2Vd2 T cells in primary Mtb infection.
Clonal immune responses of Vc2Vd2 T cells and their
contribution to resistance to TB during primary Mtb infection
remain unknown. Addressing this question may require an optimal
model system for Mtb infection. We previously demonstrated that
in contrast to vaccine-protected nonhuman primates, unvaccinat-
ed juvenile macaques infected with large-dose Mtb by aerosol
exhibited delays for development and pulmonary trafficking of Ag-
specific ab and cd T effector cells producing IFNc, and developed
profound inflammatory responses and severe TB lesions in lungs
[8,9,11,17]. Notably, severe lung TB resulted in transient
extrathoracic Mtb dissemination, and a late or ‘‘secondary’’ Mtb
infection in remote organ kidney or liver without apparent TB
lesions [18]. Progressive immune activation after initial pulmonary
Mtb infection may allow IFNc-producing cd and ab T cells to
timely develop in response to a late extrathoracic Mtb infection,
and selectively traffic to the subsequently-infected remote organ
liver or kidney for mounting potential local immunity. As initial
efforts to test this presumption, we conducted comparative studies
of TCR repertoire/clonality, tissue trafficking and effector
function of Vc2Vd2 T cells in unprotected lung and in ‘‘lesions-
free’’ remote organ kidney or liver. We focus on Vc2Vd2 T cells
because these cells can readily undergo trans-endothelial mucosal
migration after activation and expansion in lymphoid system [15].
Results
Broad TCR repertoire for Vc2Vd2 T-cell subpopulation in
lymphoid system during primary Mtb infection of
macaques
We previously demonstrated that mycobacterium-specific
Vc2Vd2 T cells could expand in lymphoid tissues, and traffic to
and accumulate in the interstitial compartment of non-lymphoid
tissues at 1–1.5 months after Mtb infection by aerosol route [18].
However, little is known about TCR repertoire of these antigen-
specific cd T cells and their tissue trafficking patterns during
infection. As an initial comparative study, we examined the
clonality and TCR repertoires of Vc2Vd2 T cells in the blood and
spleens during Mtb infection of macaques. We chose spleens as
representative lymphoid tissues in this study as spleen tissues
accommodated larger increases in Vc2Vd2 T cells than lymph
nodes in TB [18] and were more readily available at necropsy.
There was no apparent expansion of blood Vc2Vd2 T cells
overtime after Mtb infection [18]. This appeared to be relevant to
the infection route and Mtb bacterial burden, as intravenous
infection of macaques with mycobacteria led to high bacterial
burden in the blood or systemic site and induced major expansion
of blood Vc2Vd2 T cells [7,18,19]. Blood Vc2Vd2 T cells
displayed polyclonal Vd2-bearing TCR sequences at 1–1.5 month
after pulmonary Mtb infection (Fig. 1). The broad Vd2 TCR
repertoire was also seen in the blood circulation before
infection([11] and data not shown). Interestingly, whereas Vc2Vd2
T cells in spleens expanded to the level of 1565% (means6 SD) in
total CD3+ T cells at 1–1.5 month after pulmonary Mtb infection
(,2% in naı ¨ve controls, [18]), these expanded cd T cells expressed
remarkable polyclonal Vd2 TCR sequences (Fig. 1). The Vd2
TCR repertoire appeared to be quite broad because most clones
isolated from spleen tissues of Mtb-infected macaques were not
seen in the clonotypic TCR sequences identified in the blood
circulation at the time these macaques developed severe TB
(Fig. 1). Three different Jd segments were employed by the TCR
clones (Fig. 1). However, some TCR clones were more frequently
present in expanded Vc2Vd2 T cells isolated from spleen tissues of
the infected macaques. For examples, clone #2 from macaque
2717 or clones #2 and #4 from macaque 2935 accounted for
almost ,50% of the total Vd2 TCR clones identified in splenic
Vc2Vd2 T cells, and a number of subdominant clones (frequencies
were 10–15%) were also seen in splenic Vd2 TCR clones from
three infected macaques (Fig. 1). Thus, these results suggested that
Vc2Vd2 TCR repertoire in lymphoid system remained broad
after pulmonary Mtb infection, with polyclonal expansion of
HMBPP-specific Vc2Vd2 T cells in spleen tissues.
Polyclonally-expanded Vc2Vd2 T cells from lymphoid
tissues appeared to distribute and localize in lung TB
granuloms after Mtb infection by aerosol
We then sought to examine TCR repertoire and potential
clonotypic trafficking for expanded Vc2Vd2 T cells in the infection
site, lung tissue, after Mtb infection by aerosol. Apparently, many
Vc2Vd2 T cells distributed and accumulated in TB granulomas
lesions after Mtb infection by aerosol [18], and Vc2Vd2 T cells
comprised 2365% of total CD3+ T cells isolated from lung tissues
([18], ,2% of lung T cells in naı ¨ve controls). Notably, Vd2T C R
clones identified in pulmonary Vc2Vd2 T cells were polyclonal,
with many distinct clonotypes (Fig. 2). Despite such diverse TCR
repertoire, however, a number of clones that sub-dominantly
expanded in lymphoid tissues appeared to distribute in lungs since
they were repeatedly detected with frequencies of 15–20% in all the
clones isolated from lung tissues (Fig. 2). Moreover, five of these
pulmonary clones were also present in the blood circulation
(macaques 2717, 2722, 3055, 2823) or in both blood and
spleen(3055,2823), or in both blood and kidney(2717), implicating
that thesesubdominant cloneshadtraffickedtolung tissues from the
lymphoid system after Mtb infection by aerosol. These results
therefore suggested that polyclonally-expanded Vc2Vd2 T cells
from lymphoid tissues appeared to distribute and localize in severe
lung TB tissues after Mtb infection by aerosol route.
Some Vd2 T cell clones of Vc2Vd2 T-cell subpopulation
appeared to be more predominant than others in lately
Mtb-infected liver or kidney tissue
The next immunological question was whether patterns of
Vc2Vd2 T cell repertoire in remote organs(away from the lung
TCR Repertoire of cd T Cells
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heavily-infected lungs. We chose kidney and liver as representative
remote non-lymphoid organs as a late and subtle Mtb infection was
anticipated in these organs after transient extrathoracic Mtb
dissemination due to severe lung TB [18], and as progressively-
activated Vc2Vd2 T effector cells after initial pulmonary exposure
to Mtb might exhibit different TCR repertoires or trafficking
patterns in timely response to a late Mtb infection of kidney or liver.
We found that Vc2Vd2 T cells trafficked to and localized in
endothelia-interstitial tissue interface of liver and kidney in
response to lately Mtb infection [18]. The late Mtb infection led
to increases in numbers of Vc2Vd2 T cells to 25% and 32% of
total CD3+ T cells in liver and kidney, respectively, whereas in
naı ¨ve control macaques Vc2Vd2 T cells comprised ,2% of total
CD3+ T cells isolated from kidney or liver tissues [18].
Surprisingly, expanded Vc2Vd2 T cells in these remote organs
from three of five macaques exhibited dominance of a single clone
or oligo-clones bearing a selected CDR3 length, although one
macaque (2722) did not show such predominance (Fig. 3). In fact,
a single dominant clone could comprise .90% of 52 cDNA clones
derived from Vc2Vd2 T cells in kidney tissues of macaques 2717
and 3055(Fig. 3). Macaque 2935 exhibited two dominant clones
Figure 1. Broad T cell repertoire in Vc2Vd2 T-cell subpopulation in lymphoid system during primary Mtb infection of macaques.
Shown are individual Vd2 TCR clones isolated from PBL (left) and lymphocytes of spleen tissues (right) from 5 Mtb-infected macaques. The flow
cytometry data indicating cellular expansion of Vc2Vd2 T cells in spleen were described in the text. Note that spleen lymphocytes in which major
expansion of Vc2Vd2 T cells was seen were used for RNA isolation, cDNA synthesis and Vd2 TCR sequence analyses. Note polyclonal sequences of Vd2
TCR in cDNA derived from spleen lymphocytes and PBLs. Frequencies were expressed as the number of individual clones among the total analyzed
clones. Similar data indicating polyclonal representation of Vc2Vd2 T cells in PBL before Mtb infection were also seen (data not shown). CDR3 were
presumably indicated based on the definition for TCR b CDR3 [9]. D indicates diversity region; N indicates non-determining region of TCR receptor
genes. Clones marked by ‘¤’ were present in the blood, lung and kidney (2717). Clones marked by ‘#’ and ‘N
’ were present in the blood, lung and
spleen(3055 and 2823). Clones marked by ‘m’ and ‘&’ were present in the blood and lung(2722).
doi:10.1371/journal.pone.0030631.g001
Figure 2. Polyclonally-expanded Vc2Vd2 T cells from lymphoid tissues appeared to distribute and localize in lung TB granuloms
after Mtb infection by aerosol. Shown are individual Vd2 TCR clones isolated from lymphocytes of lung tissues from five Mtb-infected macaques.
The immunohistochenistry data showing infiltration and distribution of Vc2Vd2 T cells in TB granulomas were shown in the previous publication [18].
Flow cytometry data indicating cellular expansion of Vc2Vd2 T cells in CD3+ T cells isolated from the lung tissues were described in the text. Note
polyclonal Vd2 TCR sequences and sub-dominant clones in cDNA derived from lung lymphocytes in which expansion of Vc2Vd2 T cells was detected.
Clones present in blood and spleen were marked as described in the legend of Fig. 1.
doi:10.1371/journal.pone.0030631.g002
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identified in the kidney tissues (Fig. 3). While macaque 2823
exhibited polyclonal TCR clonotypes, 4 sub-dominant clones
bearing 11 aa in CDR3 comprised ,52% of all the clones
identified in the kidney (Fig. 3).
Similarly, expanded Vc2Vd2 T cells in liver tissues from four
infected macaques also displayed dominance of a single TCR clone
or clones with a restricted CDR3 length (Fig. 3). Virtually, only one
single clonotypic TCR sequence was found in cDNA clones isolated
from the expanded Vc2Vd2 T cells in liver tissues of the macaques
2717 and 2823; one single clonotypic TCR was found accounting
for almost 50% of all the clones derived from the liver of the
macaque 2935 (Fig. 3). Although expanded Vc2Vd2 T cells from
the macaque 3055 showed polyclonal Vd2 TCR sequences, ,36%
of these clones shared a same CDR3 length, 13 aa (Fig. 3).
Furthermore, we sought to determine whether Vc2Vd2 T-cell
subpopulation in remote tissues were more clonally dominated or
restricted than in blood/spleen or lung. We employed two-tailed
Fisher exact test, as previously described [20,21], to examine
whether there were significant differences in dominant Vd2
clonotypes (perturbation of TCR repertoire) between blood,
spleen, lung, liver and kidney tissue compartments. We found
that Vd2 TCR repertoires in liver and kidney tissues were more
clonally dominated or significantly perturbed when compared to
those in the blood/lung and spleen (Table 1). The TCR repertoire
in spleen was more clonally dominated than that in the blood and
lung (Table 1).
Taken together, some Vd2 T cell clones of Vc2Vd2 T-cell
subpopulation appeared to be more predominant than others in
lately Mtb-infected liver or kidney.
Figure 3. Some Vd2 T cell clones of Vc2Vd2 T-cell subpopulation appeared to be more predominant than others in lately Mtb-
infected liver or kidney. The localization of Vc2Vd2 T cells in interstitial tissues of kidney or liver were shown in the previous publication [18].
Expansion of Vc2Vd2 T cells in CD3+ T cells isolated from the kidney or liver tissues were described in the text. Note that three macaques(2717, 3055,
2935) exhibited dominance of a single clone or oligo-clones bearing a same length of CDR3 in TCR cDNA derived from kidney lymphocytes in which
expansion of Vc2Vd2 T cells was detected. In cDNA derived from liver lymphocytes, a dominance of a single TCR clone or clones with a restricted
CDR3 length was also noted in three macaques (2717, 2823, 2935). Clones marked by ‘¤’were present in the blood,lung and kidney(2717).
doi:10.1371/journal.pone.0030631.g003
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selected CDR3 length in expanded Vc2Vd2 T cells in
kidney/liver tissue compartments in ‘‘secondary’’ local
Mtb infection
The dominance of a single TCRclone orCDR3 length at sequences
levels prompted us to perform TCR CDR3 spetratyping, as we
previouslydid [22], foran additionalTCR repertoire analysis.Notably,
the profiles of CDR3 lengths in Vd2 TCR cDNA from blood, spleen
and lung of the Mtb-infected macaques were diverse without a
restricted selection of a single CDR3 length (Fig. 4). Overall, the
occurrence of multiple CDR3 lengths in these tissues was consistent
with polyclonal representations of clonotypic TCR sequences as seen in
conventional cloning/sequencing analyses (Figs. 1,2,3). In contrast,
Vd2 TCR cDNA derived from expanded Vc2Vd2 T cells in kidney
and liver tissues of four infected macaques could exhibit predominance
of a selected CDR3 length (Fig. 4). These selected individual CDR3
lengths appeared to correspond to the clonotypic CDR3 sequen-
ces(VDDJ) as shown in Fig. 3. In fact, the predominant CDR3 lengths
predictive of 13 aa, 11 aa and 16 aa detected in Vd2T C Rc D N Af r o m
kidney tissues of three macaques 2717, 2935 and 3055 were
explainable by the dominant TCR clones bearing the same CDR3
sequence lengths found in these animals, respectively (Fig. 3). Similarly,
the predominant CDR3 lengths of 10 aa, 16aa and 12aa from liver
tissues of macaques 2717, 2935 and 2823 were consistent with those
dominant TCR clones bearing the same CDR3 lengths in these
animals, respectively (Fig. 3). For the macaque 3055, a predominant
CDR3 length predictive of 13 aa was revealed in Vd2T C Rc D N A
from the liver, which was not contradictory to the found polyclonal
Vd2 TCR sequences as 5 different TCR clones accounting for almost
,40% of the total clones shared a same CDR3 length of 13 aa(Fig. 3).
Subtle, focal Mtb infection might contribute to the predominance of a
single TCR clone or CDR3 length in the kidney or liver, because
unexpanded Vc2Vd2 T cells from kidney or liver tissues of naı ¨ve
control macaques did not exhibit dominance of a selected CDR3
length(data not shown). Thus, the results from CDR3 spetratyping
analyses supported the frequency data of Vd2 TCR sequences,
suggesting that Vc2Vd2 T cellsaccumulating in kidney and livertissues
after late or secondary infection could exhibit either dominance of
single TCR clone/CDR3 length or polyclonal representation
Clonal dominance of expanded Vc2Vd2 T cells in lately-
infected kidney/liver tissues was associated with
undetectable or low-level TB burdens
The trend for clonal dominance of expanded Vc2Vd2 T cells in
kidneys and livers but not in lungs after pulmonary Mtb infection
raised a question as to whether TB burden could impact TCR
repertoire and trafficking patterns of Vc2Vd2 T cells in non-
lymphoid tissues. The severe TB lesions (extensive caseating and
miliary lesions or caseation pneumonia) and high-level TB burdens
(.7000 bacilli organisms per 10 mg tissue cells) in lungs were
found coincident with polyclonal representation with some clonal
sub-dominance in expanded Vc2Vd2 T cells from lungs of all the
unvaccinated macaques. Interestingly, clonal dominance of
expanded Vc2Vd2 T cells in the lately-infected remote organs
such as kidney and liver was associated with undetectable or low-
level TB burdens. In fact, while four macaques (2717, 2935, 2823,
3055) exhibited clonal dominance of Vc2Vd2 T cells in kidney or
liver tissues, we detected no or only a few bacilli organisms in
kidney or liver tissues from three of these macaques 2717, 2935,
and 2823, and ,400 bacilli organisms in liver/kidney tissues from
the macaque 3055. However, in the macaque 2722 that did not
exhibit clonal dominance, .1300 bacilli organisms were detected
in the liver/kidney tissues. Overall, the Mtb burdens in lung tissues
were significantly higher than those in liver or kidney
tissues(p,0.011). Notably, no TB lesions were seen in kidneys
from all macaques, and only a few small non- caseating
granulomas were found in the liver tissues from two macaques
2722(no apparent clonal dominance) and 3055, but not in the
other three macaques who exhibited clonal dominance in liver
tissues. Thus, clonal dominance of expanded Vc2Vd2 T cells in
the lately-infected organ kidney or liver was associated with
undetectable or low-level TB burden.
Vc2Vd2 T cells that accumulated in tissue compartments
could mount effector function and produce anti-
mycobacterium cytokine
Finally, we asked an interesting question as to whether Vc2Vd2
T cells that trafficked to and localized in non-lymphoid tissues such
as lung and liver could mount effector function producing
cytokines in response to phospholigand. We evaluated antigen-
driven production of IFN-c as this cytokine has been shown to be
critical for anti-TB immunity in murine TB model and as Vc2Vd2
T effector cells could produce copious amounts of IFN-c [15].
Interestingly, Vc2Vd2 T cells isolated from lung and liver tissues
were able to produce IFN-c in response to phospholigand IPP
stimulation in vitro (Fig. 5). The numbers of Vc2Vd2 T effector
cells producing IFN-c in the tissue compartments were slightly
higher than those in PBL (Fig. 5). Thus, these results suggest that
significant numbers of Vc2Vd2 T cells that localized in the lung
and liver had effector function producing anti-TB cytokine, IFN-c,
in response to IPP stimulation.
Discussion
The TCR repertoire of mycobacterium-specific Vc2Vd2 T cells
appears to be extremely broad at the level of a single Vd2
recombination with Jd/Cd genes. Most TCR clones found in the
lymphoid system, lung, kidney and liver were distinct despite that a
few clonotypes in the blood could be repeatedly identified in the
spleen, kidney or lung tissues. Notably, all three Jd segments were
employed by Vc2Vd2 T cells. In fact, we previously found that
even in the down-regulation of cd T cells during advanced
SIVmac infection, TCR repertoires of macaque Vc2Vd2 T cells
Table 1. P values derived from statistical analyses of
frequencies of dominant Vd2 clonotypes between different
tissues compartments (n=5).
Spleen Lung Liver Kidney
Blood, vs# 0.0041, ** 0.4855 0.0001, *** 0.0001, ***
Spleen, vs 0.0238, * 0.0001, *** 0.0001, ***
Lung, vs 0.0001, *** 0.0001, ***
Liver, vs 0.3726
#p value=0.0041(**, very significant) when frequencies of dominant Vd2
clonotypes in blood were compared with those in spleen(Blood vs Spleen).
Individual dominant Vd2 clonotypes were defined if they comprised .20% of
the clones identified in a tissue compartment or blood from a macaque.
Frequencies of dominant Vd2 clonotypes among total TCR clones in a
compartment from five macaques (Figs. 1, 2, 3) were calculated and analyzed
for statistical significance between different tissue compartments using two-
tailed Fisher exact test. We also statistically compared percentage numbers for
total distinct Vd2-bearing clones between different tissues compartments
(n=5), and found similar trends of results suggesting that Vd2 repertoires in
blood and lung were significantly broader than those in liver and kidney(data
not shown).
doi:10.1371/journal.pone.0030631.t001
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clonotypes in the blood [23]. Broad TCR repertoires may be
attributed to the repeated DN-DN regions and the unlimited
selection of 3 Jd segments during the TCR development.
Functionally, broad TCR repertoires of Vc2Vd2 T cells appear
to allow these cd T cells to massively proliferate and expand
without constraints. In fact, HMBPP plus IL-2 treatment or
mycobacterial infections can rapidly induce up to 400-fold
expansion of Vc2Vd2 T cells or up to 80% from a baseline level
1% of CD3+ T cells [15,24].
We have already demonstrated that at 1–2 months after Mtb
infection by aerosol route, macaques exhibit increases in numbers
of Vc2Vd2 T cells in the pulmonary compartment after their
proliferation and expansion in lymphoid tissues [11,18]. In
lymphoid tissues and lungs, Vc2Vd2 T cells expanded up to
30% from baseline ,2% in total CD3+ T cells of the tissues after
Mtb infection [18], and numerous Vc2Vd2 T cells were infiltrated
to lungs and distributed in TB granulomas [18]. Now, molecular
analyses of the expanded Vc2Vd2 T cells in spleen and lung
tissues clearly revealed polyclonal representations of cd TCR
clones and some ‘‘clonal sub-dominance’’ of some Vd2 clonotypes.
Therefore, we interpreted our findings as polyclonal expansion of
Vc2Vd2 T cells since at least 10–16 unique and representative
TCR clones or sequences were identified in expanded Vc2Vd2T
cells from lungs and spleens of four of five macaques. We
temporally used the term ‘‘clonal sub-dominance’’ in that a
number of these TCR clonotypic sequences could sub-dominantly
emerge in frequencies 15–20% of all the Vd2-bearing TCR clones
identified in cDNA derived from spleen or lung tissues of the Mtb-
infected macaques. The sub-dominance of some Vc2Vd2 T-cell
clones may be explained by the notion that these clones may
express particular phenotypes such as cytokine receptors or
memory markers and somehow more favorably proliferate and
expand in spleens or lymphoid tissues during immune responses to
Mtb infection [25]. On the other hand, other clones may more
readily traffic to and accumulate in lung TB granulomas due to
expressions of chemokine receptors [15].
One of the novel findings in the current study was that some
selected TCR clones could be dominantly present in the expanded
Vc2Vd2 T cells in kidney without TB lesions or liver with no or
subtle TB during a late and subtle Mtb infection of these remote
organs. The finding at sequence levels was consistent with the
dominance of a selected CDR3 length of Vd2 junctional regions as
revealed by TCR CDR3 spetratyping analyses. Virtually, four of
five macaques exhibited such clonal dominance among expanded
Vc2Vd2 T cells in the remote organ (kidney or liver) after
pulmonary Mtb infection by aerosol route, and, interestingly, these
macaques exhibited undetectable or low-level Mtb burdens with
no or very subtle TB lesions in kidney or liver tissues. This was in
Figure 4. TCR CDR3 spetratyping revealed predominance of a selected CDR3 length in expanded Vc2Vd2 T cells in kidney/liver
tissue compartments in late local Mtb infection. Shown are the Vd2 TCR CDR3 profiles revealed by Genescan-based spectratyping as previously
described [22]. The numbers of nucleotides in the different CDR3 lengths were determined in control experiments [22], and were expressed as
predicted numbers of amino acids. A short line at the bottom of each histogram represents the predicted CDR3 length of 12 aa. The profiles of CDR3
lengths in Vd2 TCR cDNA from blood, spleen and lung of the Mtb-infected macaques were diverse without a restricted selection of a single CDR3
length. In contrast, Vd2 TCR cDNA derived from expanded Vc2Vd2 T cells in kidney or liver tissues of four infected macaques exhibited predominance
of a selected CDR3 length. A selected CDR3 length was consistent with the clonal dominance of TCR sequence analyses in Fig. 3.
doi:10.1371/journal.pone.0030631.g004
Figure 5. Vc2Vd2 T cells that accumulated in tissue compart-
ments could mount effector function and produce anti-TB
cytokine. Shown are ELISPOT data for IPP-driven IFNc+ cellular
response in lymphocytes from blood, lung and liver collected from
four Mtb-infected macaques at 4–6 weeks after the infection. Data were
subtracted from values of glucose/medium control and expressed here
as IFNc+ Vc2Vd2 T cells in 10‘6 lymphocytes. IPP stimulates activation
of only Vc2Vd2 T cells but not other immune cells.
doi:10.1371/journal.pone.0030631.g005
TCR Repertoire of cd T Cells
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high-level Mtb burdens were coincident with polyclonal represen-
tation, rather than clonal dominance, of Vc2Vd2 T cells. This
finding suggests that TB burdens appear to impact TCR
repertoires and tissue trafficking patterns of expanded Vc2Vd2
T cells. Polyclonal representation in heavily-infected lungs may
result predominantly from simple infiltration or influx due to TB
lesions in lung tissues. The mechanism by which clonal dominance
of some selected Vc2Vd2 T-cell clones in subtly-infected liver or
kidney tissues is currently not known. It is likely that low-level Mtb
infection without apparent TB lesions in these tissues may provide
cytokine or chemokine environment in which to favor trans-
endothelial migration of the selected Vc2Vd2 T cell clone(s) that
express relevant receptors for cytokines/chemokines [26]. This
scenario is indeed supported by published human studies
demonstrating that some restricted cd TCR can be detected in
gut mucosa [27] and inflammatory kidney tissues of patients with
IgA nephropathy [28].
Another interesting observation in the current study was that
Vc2Vd2 T cells that trafficked to and accumulated in tissue
compartments of lung and liver were capable of mounting effector
function producing anti-TB cytokine IFNc in response to
phospholigand stimulation in vitro. This is in contrast to the
speculation that most T cells infiltrating in tissues of inflammatory
non-lymphoid organs would be end-terminal or exhausted cells.
Our finding suggests that Vc2Vd2 T cells accumulated in lung and
liver tissues are able to re-recognize phosphoantigen and efficiently
mount effector function of IFNc cytokine production. IFNc has
been shown to play a role in protection against active Mtb
infection in mice [5]. While human studies have not found a
correlation between blood IFNc and protection against TB, our
recent mechanistic studies suggest that rapid pulmonary trafficking
of mycobacterium-specific CD4+ and CD8+ T effector cells
producing IFNc appears to be one of the mechanisms underlying
BCG vaccine-induced immunity against primary TB [9].
Our current findings raise an interesting question as to whether
timely response of Vc2Vd2 T effector cells might indeed
contribute to the resistance to TB lesions during late and subtle
Mtb infection of liver or kidney tissues after dissemination of
pulmonary Mtb infection. We have shown that unlike vaccine-
protected macaques, unvaccinated animals infected respiratorily
with ,500 CFU Mtb exhibit significant delays for development
and pulmonary trafficking of Ag-specific ab and cd T effector cells
producing IFNc and develop severe TB lesions in lungs [8,9,11].
Severe TB was associated with transient extrathoracic Mtb
dissemination at ,10–20 days after pulmonary Mtb infection
[18], and subsequently led to a late and subtle infection in remote
organs (kidney and liver). Activation of Vc2Vd2 T cells may be
initiated sometime after pulmonary Mtb infection, and be
augmented appreciably at the time (days10–20) when a late/
subtle infection is anticipated in the kidney/liver. The clonal
dominance of expanded Vc2Vd2 T cells in kidney or liver suggests
that these cd T cells might efficiently traffic to kidney/liver tissues
before Mtb mediates damages or lesions in these organs. It is
noteworthy that Vc2Vd2 T effector cells could confer homeostatic
protection against lung plague lesions [16], and that IFNc-
producing Vc2Vd2 T cells were present in ‘‘lesions-free’’ kidney or
liver after a late/subtle infection in these remote organs (Figs. 3,5,
and [18]). Although current study did not have a power to
conclude, our findings provide a rationale to conduct future
studies to determine if timely response of Vc2Vd2 T effectors plays
a role in limiting TB lesions during a late/subtle Mtb infection of
the remote organ kidney or liver after initial pulmonary exposure
to Mtb.
Methods
Ethics statement
The nonhuman primates were used because only primates, but
not other species, have TB-specific gamma delta T cells(Vc2Vd2T
cells), and because the study cannot be done in humans. The use of
macaques and experimental procedures were approved by our
Institutional Animal Care and Use Committee (Animal Care
Committee), and Institutiaonal Biosafety Committee, and we
followed the national and international guidelines regarding ‘‘The
use of non-human primates in research’’ to minimize potential
suffering of the studied macaques. All the animals were observed 3
times a week and daily after Mtb infection to ensure that animals
would not suffer from severe coughing, respiratory distress, weight
loss and other potential life-threatening symptoms. Humane
euthanization procedures were immediately taken if these symp-
toms occur or progress. Animals were sedated by Ketamine before
sampling, and euthanized by Phentobarbital at the endpoint.
Macaque animals and M. tuberculosis infection
Indian rhesus macaques, 2 years old, were included in these
studies. Healthy unvaccinated macaques (animal IDs: Mm2717;
Mm2722, Mm3055, Mm2935) were infected with 400–500 CFU
Mtb (Rv37 strain) by aerosol route. These macaques were
euthanized for gross pathology, bacteriology, and immunology
studies at 1–1.5 months after the infection [9,18]. A BCG-
vaccinated macaque (Mm2823) were infected for 2.5-months with
Mtb, then received 3-month daily treatment with anti-TB drugs[
isoniazid (5 mg/kg) and pyrazinamide (15 mg/kg) mixing with
yogurt as previously described [8] ], and finally re-infected with
Mtb again by aerosol. Complete necropsy studies were done one
month after Mtb re-infection. All the animal protocols for the
studies were IACUC-approved.
Isolation of single cell suspensions and lymphocytes from
blood, lymphoid tissues, and non-lymphoid tissues from
the rhesus macaques
PBL were isolated from EDTA blood of the monkeys using
Ficoll/diatrizoate gradient centrifugation. Spleen tissues were
carefully teased to generate single-cell suspensions. Tissue pieces
from lungs, livers, and kidneys were minced in RPMI medium, as
previously described [19,29], to collect single cell suspensions
(mainly lymphocytes and tissue macrophages). The single cells
suspensions from these non-lymphoid organs were divided into
three parts: one directly used for mycobacterial CFU counts [8];
one directly saved as pellets for real time quantitation of M.
tuberculosis Ag85B RNA [18]; one subjected to isolation of
lymphocytes by Ficoll/diatrizoate gradient centrifugation for flow
cytometry-based analyses of cd T cells and molecular studies of cd
TCR repertoires.
Flow cytometry analyses of Vc2Vd2 T cells
Rhesus lymphocytes isolated from the blood and lymphoid and
non-lymphoid tissues were stained immunologically with anti-Vc2,
anti-Vd2, anti-Cd (Pan cd), and anti-CD3 antibodies, as described
previously [22]. Isotype-matched Ig or anti-Vd3 Ab in combina-
tion with other antibodies served as controls as previously
described [22].
ELISPOT measuring of phosphoantigen-specific IFNc-
producing Vc2Vd2 T cells
The assay was done as previously described [9,18]. Phosphoan-
tigen isopentenyl pyrophosphate (IPP) was purchased from Sigma
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The justification is that IPP is recognized only by Vc2Vd2 T cells
but not other immune cells.
Bacterial colony forming units (CFU) counts
Mtb infection levels in the blood, lung cells and other tissue cells
were determined by the quantitation of bacillus CFUs in cell
lysates from tissues cells of Mtb-infected macaques, as previously
described [8,11,18].
The real time quantitative PCR for quantitation of M.
tuberculosis Ag85B mRNA
This was done as previously described [8,18].
Gross and microscopic analyses of TB lesions
Semi-quantitative pathology analyses were done as previously
described [8,9,18].
Isolation of RNA from cells and cDNA synthesis. Total
RNA was isolated from PBL or lymphocytes isolated from spleen,
lung, liver and kidney tissues of the infected macaques using the
TRIzol isolation method [30]. The RNA pellet was resuspended in
RNase-free deionized water and then used immediately for
synthesis of cDNA using the protocol provided in the cDNA
synthesis kit from Clontech Laboratories (Palo Alto, CA).
Cloning and sequencing of Vd2-bearing TCR
Molecular cloning and sequencing of Vd2
+ T cells were done
using a PCR-based technique as described previously [11,23].
cDNA derived from PBL obtained before and after Mtb infection
as well as from lymphocytes isolated from lung, liver and kidney
tissues of the infected macaques. We used these tissue lymphocytes
for studies of cd TCR repertoires because marked expansions of
Vc2Vd2 T cells were identified in the infected macaques. Vd2
TCR cDNA was then amplified by a 30-cycle PCR using a pair of
Vd2- and Cd-specific primers that bear EcoRI and XbaI
restriction sites, respectively. The sequences for the primers were
as follows: Vd2,59-GCGCGAATTCAACGGATGGTTTGG-
TATGAGG-39;C d,59-GCGCTCTAGATATATCAACTGGT-
ACAGG-39. The specific PCR products were gel-purified,
digested with EcoRI and XbaI and ligated into the plasmid
SP65 (Promega, Madison, Wisconsin) for cloning and sequencing.
Strategy for sequencing and frequency analyses of TCR
cDNA clones. Given that Vd2 TCR repertoire were quite
diverse even in SIVmac-infected macaques [23], we initially
sequenced 25 TCR clones isolated from cDNA derived from
Vc2Vd2 T cells. If the frequency for one or two of clonotypes was
.20% of all clones analyzed, additional 20–25 clones were
sequenced and analyzed.
TCR CDR3 spetratyping of Vd2
+ T cells
CDR3 profiles were analyzed by Genescan-based spectratyping
as we previously described [22]. cDNAs were amplified by PCR
for expression of Vd2 family gene using a Vd2-specific primer (59-
GGGGACCCTGCCACCCTCAAGTGC-39) and a Cd-specific
primer (59-CTTGGGGTAGAAGTCCTTCAC-39). A second
round of PCR was performed using an internal Vd2 primer (59-
ATGAAAGGAGAAGCAATCAGTAAC-39) and an internal Cd
primer (59-CAGACAAGCAACATTTGTCCC-39). The internal
Cd primer was labeled at its 59 end with the Fam fluorophore
(Applied Biosystems, Foster City, CA), designed as previously
described [22]. The first and second round PCR were amplified
for 35 and 15 cycles, respectively, using the following conditions:
95uC for 30 seconds, 60uC for 30 seconds, and 72uC for
30 seconds. One micro liter of each reaction product was mixed
with deionized formamide and a ROCK-500 size standard, and
then electrophoresed on a 5% acrylamide gel on a 310 DNA
sequencer (Applied Biosystems, Foster City, CA). Data were
analyzed for size and fluorescence intensity using the Genescan
software. These lengths were expressed as predicted numbers of
amino acids [22].
Statistical analysis
The multivariate analysis of variance (ANOVA) and student t
test were used, as previously described [29], to statistically analyze
the data for differences in Vc2Vd2 T cells numbers or M.
tuberculosis burdens between tissues/organs. We also employed two-
tailed Fisher exact test, as previously described [20,21], to examine
whether there were significant differences in dominant Vd2
clonotypes (perturbation of TCR repertoire) between blood,
spleen, lung, liver and kidney tissue compartments. Any clones
comprising $20% of the clones identified in a tissue compartment
of a macaque were defined as dominant Vd2 clonatypes, and the
frequencies of these dominant Vd2 clonotypes in a given tissue
compartment from total five macaques were calculated and
compared statistically with those in individual different tissue
compartments. We also statistically compared percentage numbers
of total distinct Vd2-bearing clones between different tissues
compartments (n=5),
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